Bio-Rad Laboratories, Inc. Share Price
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 297.09 USD | +1.19% |
|
+6.08% | -1.95% |
| 07-01 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| 06-03 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
| Market Cap | 7.95B 6.98B 6.42B 5.99B 11.29B 756B 11.52B 77.25B 29.93B 371B 29.84B 29.2B 1,291B | P/E 2026 * |
35.7x | P/E 2027 * | 34.9x |
|---|---|---|---|---|---|
| Enterprise Value | 7.2B 6.32B 5.82B 5.42B 10.22B 684B 10.43B 69.97B 27.11B 336B 27.03B 26.44B 1,169B | EV / Sales 2026 * |
2.8x | EV / Sales 2027 * | 2.65x |
| Free-Float |
60.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +1.19% | ||
| 1 week | +6.08% | ||
| Current month | +1.19% | ||
| 1 month | -2.74% | ||
| 3 months | +6.73% | ||
| 6 months | -1.95% | ||
| Current year | -1.95% |
| 1 week | 287.94 |  | 305 |
| 1 month | 270 | | 312.27 |
| Current year | 236.73 | | 328.56 |
| 1 year | 236.73 | | 343.12 |
| 3 years | 211.43 | | 431.79 |
| 5 years | 211.43 | | 832.7 |
| 10 years | 140.53 | | 832.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 31/12/2002 |
| President | 61 | 08/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 14/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 31/12/2011 |
Jeffrey Edwards
BRD | Director/Board Member | 65 | 24/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 24/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-10 | Sell | Executive/Senior Manager | -550 | 0.0025% | ||
| 04-23 | Fiscal year | General Counsel | 449 | 0.0020% | ||
| 04-23 | Fiscal year | Chief Financial Officer | 2,576 | 0.0117% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.19% | +6.08% | +19.80% | -21.64% | 7.95B | |
| +1.59% | +1.87% | -32.35% | -15.45% | 161B | |
| +1.24% | -1.16% | -10.76% | -10.10% | 101B | |
| +1.92% | +1.39% | -2.34% | +49.88% | 56.12B | |
| -0.95% | -1.76% | +54.76% | +48.28% | 53.35B | |
| +1.04% | +3.47% | -13.94% | -42.09% | 42.13B | |
| +5.81% | +15.76% | - | - | 35.29B | |
| +2.24% | -1.28% | -17.61% | -46.42% | 26.57B | |
| +1.67% | +7.22% | +64.10% | -4.57% | 25.79B | |
| +0.82% | +2.48% | -12.51% | -5.64% | 20.69B | |
| Average | +1.66% | +3.66% | +5.46% | -5.30% | 52.98B | |
| Weighted average by Cap. | +1.54% | +2.10% | -6.06% | -3.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.25B 2.07B 1.93B 3.65B 244B 3.72B 24.95B 9.67B 120B 9.64B 9.43B 417B | 2.63B 2.31B 2.13B 1.98B 3.74B 250B 3.82B 25.61B 9.92B 123B 9.89B 9.68B 428B |
| Net income | 225M 197M 182M 169M 319M 21.38B 326M 2.19B 847M 10.49B 844M 826M 36.52B | 230M 202M 186M 173M 326M 21.84B 333M 2.23B 865M 10.72B 863M 844M 37.31B |
| Net Debt | -749M -658M -605M -564M -1.06B -71.21B -1.09B -7.28B -2.82B -34.95B -2.81B -2.75B -122B | -965M -848M -780M -727M -1.37B -91.79B -1.4B -9.38B -3.64B -45.05B -3.62B -3.55B -157B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/07/26 | US$297.09 | +1.19% | 204,201 |
| 30/06/26 | US$293.61 | -0.57% | 237,364 |
| 29/06/26 | US$295.30 | -1.83% | 329,344 |
| 26/06/26 | US$300.79 | +0.84% | 481,973 |
| 25/06/26 | US$298.29 | +6.51% | 591,755 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
Select your edition
All financial news and data tailored to specific country editions
